As the larger Aetna (AET) looks to shed costs following its proposed acquisition of Humana (HUM), one key area under consideration would be to bring the management of its large amount of prescription drugs in house and turn it into a money-maker for the larger health insurer. This would mean a [...]
from Forbes Real Time http://onforb.es/1gjoDV1
Aucun commentaire:
Enregistrer un commentaire